Company / EPS (Diluted)
Dynavax Technologies Corp. EPS (Diluted) History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.20
FY2024
5-year range
-$0.78 / $1.97
FY2020-FY2024
Trend
+500.0%
vs FY2023
Sector context
#39 of 204
Health Care
What the data says
EPS (Diluted) changed +500% YoY in FY2024, a notable deviation from the 6-year average annual change of +149%.
Based on SEC 10-K filings.
0.20 in FY2024 with a 3-year CAGR of -29.5%. Top quartile in the Health Care sector.
Declined from $1.97 to $0.20 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -29.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 204This company $0.20 Sector average -$1.03
▼
+119.4% above sector average
Key checks
Key Insights
- In FY2024, eps (diluted) increased 500.0% year-over-year.
- Ranks #39 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.20 | +500.0% |
| FY2023 | -$0.05 | -102.5% |
| FY2022 | $1.97 | +245.6% |
| FY2021 | $0.57 | +173.1% |
| FY2020 | -$0.78 | +63.9% |
| FY2019 | -$2.16 | +15.3% |
| FY2018 | -$2.55 | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026